itraconazole has been researched along with Communicable Diseases, Emerging in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chindamporn, A; Permpalung, N; Worasilchai, N | 1 |
| Bezerra Moreira, JL; Branco de Souza Collares Maia, DC; Carvalho, VL; Costa Sidrim, JJ; de Aguiar Cordeiro, R; de Jesus Pinheiro Gomes Bandeira, T; de Meirelles, AC; Gadelha Rocha, MF; Negrão Silva, CP; Nogueira Brilhante, RS | 1 |
| Amorim, A; Araujo, R; Oliveira, M; Sampaio-Maia, B | 1 |
| Alvareda, D; Silva, V; Zepeda, G | 1 |
| Carey, J; D'Amico, R; Rinaldi, MG; Sutton, DA | 1 |
| Bethge, WA; Einsele, H; Hebart, H; Horger, M; Kanz, L; Kröber, SM; Schmalzing, M; Schumacher, U; Stuhler, G | 1 |
| Aggarwal, P; Capoor, MR; Deb, M; Nair, D; Srivastava, L; Verma, PK | 1 |
3 review(s) available for itraconazole and Communicable Diseases, Emerging
| Article | Year |
|---|---|
Human Pythiosis: Emergence of Fungal-Like Organism.
Topics: Anti-Bacterial Agents; Antifungal Agents; beta-Glucans; Communicable Diseases, Emerging; Drug Combinations; Eye Infections, Fungal; Immunotherapy; Itraconazole; Oomycetes; Pathology, Molecular; Pythiosis; Pythium; Serologic Tests; Spores, Fungal; Terbinafine; Thalassemia; Vascular System Injuries | 2020 |
Unpredictable susceptibility of emerging clinical moulds to tri-azoles: review of the literature and upcoming challenges for mould identification.
Topics: Antifungal Agents; Azoles; Communicable Diseases, Emerging; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Voriconazole | 2015 |
Paecilomyces lilacinus vaginitis in an immuno-competent patient.
Topics: Adult; Antifungal Agents; Communicable Diseases, Emerging; Female; Humans; Immunocompetence; Itraconazole; Mycoses; Paecilomyces; Treatment Outcome; Vaginitis | 2003 |
4 other study(ies) available for itraconazole and Communicable Diseases, Emerging
| Article | Year |
|---|---|
Bipolaris hawaiiensis as an emerging cause of cutaneous phaeohyphomycosis in an Antillean manatee Trichechus manatus manatus.
Topics: Animals; Antifungal Agents; Brazil; Communicable Diseases, Emerging; Female; Itraconazole; Mitosporic Fungi; Phaeohyphomycosis; Trichechus manatus | 2015 |
[Nosocomial urinary infection due to Trichosporon asahii. First two cases in Chile].
Topics: Amphotericin B; Antifungal Agents; Chile; Communicable Diseases, Emerging; Cross Infection; Drug Resistance, Fungal; Fatal Outcome; Fluconazole; Humans; Immunocompromised Host; Intensive Care Units; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Multiple Myeloma; Mycoses; Opportunistic Infections; Parkinson Disease; Postoperative Complications; Trichosporon; Urinary Catheterization; Urinary Tract Infections; Ventriculoperitoneal Shunt | 2003 |
Mucormycoses in patients with hematologic malignancies: an emerging fungal infection.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Communicable Diseases, Emerging; Dermatomycoses; Disease Susceptibility; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Neutropenia; Pyrimidines; Sinusitis; Transplantation Conditioning; Triazoles; Viscera; Voriconazole | 2005 |
Emergence of non-albicans Candida species and antifungal resistance in a tertiary care hospital.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Communicable Diseases, Emerging; Drug Resistance, Fungal; Female; Fluconazole; Hospitals; Humans; Itraconazole; Male | 2005 |